Galectin Therapeutics reported $-0.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Gilead Sciences USD -6.75 8.78 Jun/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 3.09 1.28 Jun/2026
Merck USD -0.13 1.15 Jun/2026